161 related articles for article (PubMed ID: 9000544)
1. Characterization of the processing and granular targeting of human proteinase 3 after transfection to the rat RBL or the murine 32D leukemic cell lines.
Garwicz D; Lindmark A; Hellmark T; Gladh M; Jögi J; Gullberg U
J Leukoc Biol; 1997 Jan; 61(1):113-23. PubMed ID: 9000544
[TBL] [Abstract][Full Text] [Related]
2. Human cathepsin G lacking functional glycosylation site is proteolytically processed and targeted for storage in granules after transfection to the rat basophilic/mast cell line RBL or the murine myeloid cell line 32D.
Garwicz D; Lindmark A; Gullberg U
J Biol Chem; 1995 Nov; 270(47):28413-8. PubMed ID: 7499346
[TBL] [Abstract][Full Text] [Related]
3. Processing of human cathepsin G after transfection to the rat basophilic/mast cell tumor line RBL.
Gullberg U; Lindmark A; Nilsson E; Persson AM; Olsson I
J Biol Chem; 1994 Oct; 269(40):25219-25. PubMed ID: 7929211
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis-induced proteinase 3 membrane expression is independent from degranulation.
Durant S; Pederzoli M; Lepelletier Y; Canteloup S; Nusbaum P; Lesavre P; Witko-Sarsat V
J Leukoc Biol; 2004 Jan; 75(1):87-98. PubMed ID: 14525959
[TBL] [Abstract][Full Text] [Related]
5. Expression of recombinant proteinase 3, the autoantigen in Wegener's granulomatosis, in insect cells.
Van der Geld YM; Smook ML; Huitema MG; Harmsen MC; Limburg PC; Kallenberg CG
J Immunol Methods; 2002 Jun; 264(1-2):195-205. PubMed ID: 12191522
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a recombinant proteinase 3, the autoantigen in Wegener's granulomatosis and its reactivity with anti-neutrophil cytoplasmic autoantibodies.
Witko-Sarsat V; Halbwachs-Mecarelli L; Almeida RP; Nusbaum P; Melchior M; Jamaleddine G; Lesavre P; Descamps-Latscha B; Gabay JE
FEBS Lett; 1996 Mar; 382(1-2):130-6. PubMed ID: 8612734
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human proteinase 3, the Wegener's autoantigen, expressed in HMC-1 cells is enzymatically active and recognized by c-ANCA.
Specks U; Fass DN; Fautsch MP; Hummel AM; Viss MA
FEBS Lett; 1996 Jul; 390(3):265-70. PubMed ID: 8706874
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the biosynthesis, processing, and sorting of human HBP/CAP37/azurocidin.
Lindmark A; Garwicz D; Rasmussen PB; Flodgaard H; Gullberg U
J Leukoc Biol; 1999 Oct; 66(4):634-43. PubMed ID: 10534120
[TBL] [Abstract][Full Text] [Related]
9. What you should know about PR3-ANCA. Conformational requirements of proteinase 3 (PR3) for enzymatic activity and recognition by PR3-ANCA.
Specks U
Arthritis Res; 2000; 2(4):263-7. PubMed ID: 11094439
[TBL] [Abstract][Full Text] [Related]
10. Cloning and functional expression of the murine homologue of proteinase 3: implications for the design of murine models of vasculitis.
Jenne DE; Fröhlich L; Hummel AM; Specks U
FEBS Lett; 1997 May; 408(2):187-90. PubMed ID: 9187364
[TBL] [Abstract][Full Text] [Related]
11. Epitope mapping of anti-PR3 antibodies using chimeric human/mouse PR3 recombinant proteins.
Selga D; Segelmark M; Wieslander J; Gunnarsson L; Hellmark T
Clin Exp Immunol; 2004 Jan; 135(1):164-72. PubMed ID: 14678279
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to early endosome antigen (EEA1) produce a staining pattern resembling cytoplasmic anti-neutrophil cytoplasmic antibodies (C-ANCA).
Selak S; Woodman RC; Fritzler MJ
Clin Exp Immunol; 2000 Dec; 122(3):493-8. PubMed ID: 11122260
[TBL] [Abstract][Full Text] [Related]
13. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils.
Van Rossum AP; van der Geld YM; Limburg PC; Kallenberg CG
Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood.
Abdel-Salam B; Iking-Konert C; Schneider M; Andrassy K; Hänsch GM
Kidney Int; 2004 Sep; 66(3):1009-17. PubMed ID: 15327394
[TBL] [Abstract][Full Text] [Related]
15. Wegener's granulomatosis: anti-proteinase 3 antibodies are potent inductors of human endothelial cell signaling and leakage response.
Sibelius U; Hattar K; Schenkel A; Noll T; Csernok E; Gross WL; Mayet WJ; Piper HM; Seeger W; Grimminger F
J Exp Med; 1998 Feb; 187(4):497-503. PubMed ID: 9463400
[TBL] [Abstract][Full Text] [Related]
16. Membrane proteinase 3 and Wegener's granulomatosis.
von Vietinghoff S; Schreiber A; Otto B; Choi M; Göbel U; Kettritz R
Clin Nephrol; 2005 Dec; 64(6):453-9. PubMed ID: 16370159
[TBL] [Abstract][Full Text] [Related]
17. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides.
Van Der Geld YM; Simpelaar A; Van Der Zee R; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG
Kidney Int; 2001 Jan; 59(1):147-59. PubMed ID: 11135067
[TBL] [Abstract][Full Text] [Related]
18. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity.
van de Wiel BA; Dolman KM; van der Meer-Gerritsen CH; Hack CE; von dem Borne AE; Goldschmeding R
Clin Exp Immunol; 1992 Dec; 90(3):409-14. PubMed ID: 1458677
[TBL] [Abstract][Full Text] [Related]
19. A proportion of proteinase 3 (PR3)-specific anti-neutrophil cytoplasmic antibodies (ANCA) only react with PR3 after cleavage of its N-terminal activation dipeptide.
Sun J; Fass DN; Viss MA; Hummel AM; Tang H; Homburger HA; Specks U
Clin Exp Immunol; 1998 Nov; 114(2):320-6. PubMed ID: 9822293
[TBL] [Abstract][Full Text] [Related]
20. Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis.
van der Geld YM; Tool AT; Videler J; de Haas M; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG; Roos D
Clin Exp Immunol; 2002 Sep; 129(3):562-70. PubMed ID: 12197900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
